Journal Report

Blood Advances

Download PDF
Journal Information
Journal Title
Blood Advances
Publisher
American Society of Hematology
ISSN
2473-9529
E-ISSN
2473-9537
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Life-years saved by advances in blood cancer therapy: a retrospective analysis
Dennis C. Chang, Ann-Kathrin Eisfeld, Lee M. Greenberger et al.
2026-11-10 Vol. 10 Issue 21 Pages 7209-7217
DOI: 10.1182/bloodadvances.2026019813
Clonal hematopoiesis in autoimmune hemolytic anemia
Stennio Da Silva Faria, Rafaël Moisan, Estelle Lecluze et al.
2026-11-10 Vol. 10 Issue 21 Pages 7251-7254
DOI: 10.1182/bloodadvances.2026021015
Affordable cure within reach for thalassemia
Akshay Sharma, Ashish O. Gupta
2026-11-10 Vol. 10 Issue 21 Pages 7281-7283
DOI: 10.1182/bloodadvances.2026021500
Genetic and laboratory predictors of bleeding severity in FVII deficiency: insights from the PRO-RBDD and EN-RBD databases
Samin Mohsenian, Andrea Cairo, Roberta Palla et al.
2026-11-10 Vol. 10 Issue 21 Pages 7187-7196
DOI: 10.1182/bloodadvances.2026020732
Comprehensive genetic characterization of adult <i>BCR</i> :: <i>ABL1</i> -negative B-ALL by optical genome mapping and targeted NGS
Josgrey Navas Acosta, Alberto Hernández-Sánchez, Ángela Villaverde-Ramiro et al.
2026-11-10 Vol. 10 Issue 21 Pages 7299-7310
DOI: 10.1182/bloodadvances.2026020029
Chemotherapy-related anemia is regulated through caspase-1–mediated ROCK1 activation
Julia Sjöberg, Anna Rydström, Oscar Hedberg et al.
2026-11-10 Vol. 10 Issue 21 Pages 7339-7351
DOI: 10.1182/bloodadvances.2026020131
Hu B, Reagan PM, Sehn LH, et al. Subgroup analysis of older patients ≥60 years with diffuse large B-cell lymphoma in the phase 3 POLARIX study. <i>Blood Adv.</i> 2025;9(10):2489-2499.
2026-11-10 Vol. 10 Issue 21 Pages 7352-7352
DOI: 10.1182/bloodadvances.2026022540
Phase 1/2 trial of Evomela for autologous transplant in myeloma: schedule optimization and matched comparison with MEL200
Qaiser Bashir, Peter F. Thall, Jitesh D. Kawedia et al.
2026-11-10 Vol. 10 Issue 21 Pages 7218-7229
DOI: 10.1182/bloodadvances.2026020293
Adaptive NK-cell dominance linked to HLH susceptibility in VEXAS syndrome
Christopher Sjöwall, Heinrich Schlums, Lars Gerullat et al.
2026-11-10 Vol. 10 Issue 21 Pages 7264-7268
DOI: 10.1182/bloodadvances.2026020685
Assessment of the IPSS-M in chronic myelomonocytic leukemia
Laura Palomo, Mireia Morgades, Manja Meggendorfer et al.
2026-11-10 Vol. 10 Issue 21 Pages 7255-7263
DOI: 10.1182/bloodadvances.2026019760
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 20:15